The novel coronavirus of 2019 (COVID-19) can affect multiple organ systems with a wide spectrum of illness severity. Its effect on the respiratory tract is well-documented and has resulted in considerable excess mortality worldwide. However, observed cutaneous manifestations of COVID-19 are rising, ranging from short-lived viral exanthems to vesicular eruptions and urticaria. An unusual subgroup of these manifestations – pseudo-chilblains, also referred to as pernio-like lesions or ‘COVID toes’ – describes the acral areas of erythema and oedema that can affect young individuals following COVID-19. We present a case associated with pustule and vesicle formation occurring in the context of pregnancy.
Galvan CasasCCatalaACarretero HernandezG, et al.Classification of the cutaneous manifestations of COVID-19: A rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol2020; 183: 71–77.
2.
DaneshjouRRanaJDickmanM, et al.Pernio-like eruption associated with COVID-19 in skin of color. JAAD Case Rep2020; 6: 892–897.
3.
Association AAoD. Covid toes, rashes: How the coronavirus can affect your skin.2020.
4.
MehtaPBunkerCBCiurtinC, et al.Chilblain-like acral lesions in long COVID-19: Management and implications for understanding microangiopathy. Lancet Infect Dis2021; 21: 912.
5.
CappelJAWetterDA. Clinical characteristics, etiologic associations, laboratory findings, treatment, and proposal of diagnostic criteria of pernio (chilblains) in a series of 104 patients at Mayo clinic, 2000 to 2011. Mayo Clin Proc2014; 89: 207–215.
6.
CrowsonANMagroCM. Idiopathic perniosis and its mimics: A clinical and histological study of 38 cases. Hum Pathol1997; 28: 478–484.
7.
MagroCMMulveyJJLaurenceJ, et al.The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Br J Dermatol2021; 184: 141–150.
8.
Zav’yalovVPHamalainen-LaanayaHKorpelaTK, et al.Interferon-inducible myxovirus resistance proteins: Potential biomarkers for differentiating viral from bacterial infections. Clin Chem2019; 65: 739–750.
9.
Vazquez-OsorioIRocamondeLTrevino-CastellanoM, et al.Pseudo-chilblain lesions and COVID-19: a controversial relationship. Int J Dermatol2021; 60: 754–756.
10.
FreemanEEMcMahonDELipoffJB, et al.Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries. J Am Acad Dermatol2020; 83: 486–492.
11.
HubicheTCardot-LecciaNLe DuffF, et al.Clinical, laboratory, and interferon-alpha response characteristics of patients with chilblain-like lesions during the COVID-19 pandemic. JAMA Dermatol2021; 157: 202–206.
12.
YockeyLJIwasakiA. Interferons and proinflammatory cytokines in pregnancy and fetal development. Immunity2018; 49: 397–412.
